Whenever prostate cancer spreads, it is common for cancer cells to spread to the bone. This occurs because the bone provides an environment conducive to the multiplication of tumor cells, thanks to its abundant blood supply.
In addition, the connection between the spine and the ribs through the network of blood vessels facilitates the spread of the tumor in this area, causing symptoms such as pain, bone weakness, fractures and difficulty in mobility, which significantly affects the quality of life. life. At this advanced stage, other treatment options, such as chemotherapy, may be considered.
Although for a long time, it was thought that prostate cancer was “chemoresistant” and a treatment with high toxicity; however, various studies such as CHAARTED have shown that chemotherapy combined with hormonal therapy improves both castration resistance time and overall survival in patients with advanced metastatic castration-resistant prostate cancer (CRSCLC).[5].
“Today, the panorama in the treatment of prostate cancer is different thanks to advances in science; however, regular monitoring and timely assessment are still necessary to improve the prognosis of the disease”, highlights Dr. José Aurelio Athié, medical leader of Sanofi’s Hemato-Oncology therapeutic area.
“On World Prostate Cancer Day, we want to open a space for dialogue about men’s health and offer hope to all men facing this disease. We want you to know that there are various treatment options available for each stage of the disease and that chemotherapy is effective. Our goal is that they can continue to be active, productive and enjoy an excellent quality of life with their loved ones”, concludes Dr. José Athié.